Abida W, Hahn AW, Shore N, Agarwal N, et al. Phase 1 Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Progressing on Enzalutamide. Clin Cancer Res 2024 Jan 16. doi: 10.1158/1078-0432.CCR-23-3508.
PMID: 38226958